SELECT PUBLICATIONS Albain K et al. Concurrent (CAFT) versus sequential (CAF-T) chemohormonal therapy (cyclophosphamide, doxorubicin, 5-f luorouracil, tamoxifen) versus T alone for postmenopausal, node-positive, estrogen (ER) and/or progesterone (PgR) receptor positive breast cancer: Mature outcomes and new biologic correlates on Phase III Intergroup trial 0100 (SWOG-8814). San Antonio Breast Cancer Symposium 2004;Abstract 37.
|
Editor’s Note: Patrick I Borgen, MD J Michael Dixon, MD John Mackey, MD Clifford Hudis, MD
|
Terms of Use/Disclaimer Copyright © 2006 Research To Practice, All Rights Reserved |